Cite
HARVARD Citation
Ding, Z. et al. (n.d.). S723 Improvements in Work Productivity Loss and Associated Cost Reductions with Ustekinumab and Adalimumab in Biologic-Naïve Patients with Moderately-to-Severely Active Crohn's Disease: Results From the SEAVUE Study. American journal of gastroenterology. p. S330. [Online].